多囊卵巢综合征病因及其发病机制的研究进展

doi:10.13481/j.1671-587X.20240136

Abstract

Abstract:

Polycystic ovary syndrome (PCOS) is a heterogeneous disorder closely associated with reproductive endocrine dysfunction in the women. The etiology and pathogenesis of PCOS remain unclear. PCOS is the result of the combination of endocrine metabolic disorders, genetics, and environmental factors. Hyperandrogenemia (HA) and insulin resistance (IR) are the fundamental pathophysiological changes in the development of PCOS, and their interactions exacerbate the clinical manifestations of the PCOS patients. The family aggregation and twin study results confirm the genetic predisposition of PCOS; the genome-wide association study (GWAS) results confirm some risk loci and candidate genes of PCOS. The unhealthy lifestyle habits and environmental endocrine disruptors also play an important role in the progression of PCOS, and the gut microbita is involved in the pathogenesis of PCOS. This article provides a comprehensively retrospective analysis on the recent studies about PCOS,and reviews both internal factors and external factors related to the etiology and pathogenesis of PCOS.

Key words: Polycystic ovary syndrome, Endocrine metabolic disorder, Gut microbiome, Inflammation, Environment, Genetics

CLC Number:

R711.75

Yajie GE,Wen XU,Shimin GUAN,Lina WANG. Research progress in etiology and pathogenesis of polycystic ovary syndrome[J].Journal of Jilin University(Medicine Edition), 2024, 50(1): 288-294.

References 54

1	PATEL S. Polycystic ovary syndrome （PCOS）， an inflammatory， systemic， lifestyle endocrinopathy［J］. J Steroid Biochem Mol Biol， 2018， 182： 27-36.
2	ABBARA A， DHILLO W S. Targeting elevated GnRH pulsatility to treat polycystic ovary syndrome［J］. J Clin Endocrinol Metab， 2021， 106（10）： e4275-e4277.
3	CHAUDHARI N， DAWALBHAKTA M， NAMPOOTHIRI L. GnRH dysregulation in polycystic ovarian syndrome （PCOS） is a manifestation of an altered neurotransmitter profile［J］. Reprod Biol Endocrinol， 2018， 16（1）： 37.
4	NAGAE M， UENOYAMA Y， OKAMOTO S， et al. Direct evidence that KNDy neurons maintain gonadotropin pulses and folliculogenesis as the GnRH pulse generator［J］. Proc Natl Acad Sci U S A， 2021， 118（5）： e2009156118.
5	ESPARZA L A， SCHAFER D， HO B S， et al. Hyperactive LH pulses and elevated kisspeptin and NKB gene expression in the arcuate nucleus of a PCOS mouse model［J］. Endocrinology， 2020， 161（4）： bqaa018.
6	SILVA M S B， DESROZIERS E， HESSLER S， et al. Activation of arcuate nucleus GABA neurons promotes luteinizing hormone secretion and reproductive dysfunction： implications for polycystic ovary syndrome［J］. EBioMedicine， 2019， 44： 582-596.
7	COUTINHO E A， KAUFFMAN A S. The role of the brain in the pathogenesis and physiology of polycystic ovary syndrome （PCOS）［J］. Med Sci， 2019， 7（8）： 84.
8	ROSENFIELD R L， EHRMANN D A. The pathogenesis of polycystic ovary syndrome （PCOS）： the hypothesis of PCOS as functional ovarian hyperandrogenism revisited［J］.Endocr Rev，2016，37（5）： 467-520.
9	GARG A， PATEL B， ABBARA A， et al. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome （PCOS）［J］. Clin Endocrinol， 2022， 97（2）： 156-164.
10	WALTERS K A， HANDELSMAN D J. Role of androgens in the ovary［J］. Mol Cell Endocrinol， 2018， 465： 36-47.
11	VIGIL P， CONTRERAS P， ALVARADO J L， et al. Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome［J］. Hum Reprod， 2007， 22（11）： 2974-2980.
12	IBÁÑEZ L， OBERFIELD S E， WITCHEL S， et al. An international consortium update： pathophysiology， diagnosis， and treatment of polycystic ovarian syndrome in adolescence［J］.Horm Res Paediatr，2017，88（6）：371-395.
13	TOSI F， MOLIN FDAL， ZAMBONI F， et al. Serum androgens are independent predictors of insulin clearance but not of insulin secretion in women with PCOS［J］. J Clin Endocrinol Metab， 2020， 105（5）： dgaa095.
14	LI Y， CHEN C Y， MA Y， et al. Multi-system reproductive metabolic disorder： significance for the pathogenesis and therapy of polycystic ovary syndrome （PCOS）［J］. Life Sci， 2019， 228： 167-175.
15	KELLY C C， LYALL H， PETRIE J R， et al. Low grade chronic inflammation in women with polycystic ovarian syndrome［J］. J Clin Endocrinol Metab， 2001， 86（6）： 2453-2455.
16	RUDNICKA E， KUNICKI M， SUCHTA K， et al. Inflammatory markers in women with polycystic ovary syndrome［J］. Biomed Res Int， 2020， 2020： 4092470.
17	ÖZAY A C， ÖZAY Ö E. The importance of inflammation markers in polycystic ovary syndrome［J］. Rev Assoc Med Bras （1992）， 2021， 67（3）： 411-417.
18	HE S Q， MAO X D， LEI H F， et al. Peripheral blood inflammatory-immune cells as a predictor of infertility in women with polycystic ovary syndrome［J］. J Inflamm Res， 2020， 13： 441-450.
19	ZHAI Y， PANG Y L. Systemic and ovarian inflammation in women with polycystic ovary syndrome［J］. J Reprod Immunol， 2022， 151： 103628.
20	PARK C B， LARSSON N G. Mitochondrial DNA mutations in disease and aging［J］. J Cell Biol， 2011， 193（5）： 809-818.
21	BEHBOUDI-GANDEVANI S， RAMEZANI TEHRANI F， BIDHENDI YARANDI R， et al. The association between polycystic ovary syndrome， obesity， and the serum concentration of adipokines［J］. J Endocrinol Invest， 2017， 40（8）： 859-866.
22	DROLET R， BÉLANGER C， FORTIER M， et al. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women［J］. Obesity， 2009，17（3）： 424-430.
23	PEREIRA S， PARK E， MOORE J， et al. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo ［J］. Physiol Appl Nutr Metab， 2015， 40（11）： 1129-1136.
24	ZENG X， XIE Y J， LIU Y T， et al. Polycystic ovarian syndrome： correlation between hyperandrogenism， insulin resistance and obesity［J］. Clin Chim Acta， 2020， 502： 214-221.
25	TREMELLEN K， PEARCE K. Dysbiosis of Gut Microbiota （DOGMA）：a novel theory for the development of Polycystic Ovarian Syndrome［J］. Med Hypotheses， 2012， 79（1）： 104-112.
26	ZHANG J C， SUN Z H， JIANG S M， et al. Probiotic Bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis［J］. mSystems， 2019， 4（2）： e00017-e00019.
27	TORRES P J， SIAKOWSKA M， BANASZEWSKA B，et al. Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism［J］. J Clin Endocrinol Metab， 2018， 103（4）： 1502-1511.
28	YANG Y L， ZHOU W W， WU S， et al. Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome［J］. Endocrinology， 2021， 162（10）： bqab118.
29	ZENG B， LAI Z W， SUN L J， et al. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance （IR-PCOS）： a pilot study［J］. Res Microbiol， 2019， 170（1）： 43-52.
30	HWANG I， PARK Y J， KIM Y R， et al. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity［J］. FASEB J， 2015， 29（6）：2397-2411.
31	JOBIRA B， FRANK D N， PYLE L， et al. Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota［J］. J Clin Endocrinol Metab， 2020， 105（6）： e2134-e2144.
32	ZHANG M M， HU R N， HUANG Y J， et al. Present and future： crosstalks between polycystic ovary syndrome and gut metabolites relating to gut microbiota［J］. Front Endocrinol， 2022， 13： 933110.
33	CANI P D， BIBILONI R， KNAUF C， et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice［J］. Diabetes， 2008， 57（6）： 1470-1481.
34	OUTEIRIÑO-IGLESIAS V， ROMANÍ-PÉREZ M， GONZÁLEZ-MATÍAS L C， et al. GLP-1 increases preovulatory LH source and the number of mature follicles，As well As synchronizing the onset of puberty in female rats［J］.Endocrinology，2015，156（11）：4226-4237.
35	RUTKOWSKA A， RACHOŃ D. Bisphenol A （BPA） and its potential role in the pathogenesis of the polycystic ovary syndrome （PCOS）［J］. Gynecol Endocrinol， 2014， 30（4）： 260-265.
36	KAWA I A， MASOOD A， GANIE M A， et al. Bisphenol A （BPA） acts as an endocrine disruptor in women with Polycystic Ovary Syndrome： Hormonal and metabolic evaluation［J］. Obes Med， 2019， 14： 100090.
37	DUNN A J. Environmental influences and polycystic ovarian syndrome［J］.Clin Obstet Gynecol，2021，64（1）： 33-38.
38	ABBOTT D H， BARNETT D K， BRUNS C M，et al. Androgen excess fetal programming of female reproduction： a developmental aetiology for polycystic ovary syndrome？［J］.Hum Reprod Update，2005，11（4）： 357-374.
39	YILMAZ B， VELLANKI P， ATA B， et al. Diabetes mellitus and insulin resistance in mothers， fathers， sisters， and brothers of women with polycystic ovary syndrome： a systematic review and meta-analysis［J］. Fertil Steril， 2018， 110（3）： 523-533.e14.
40	MIMOUNI N E H， PAIVA I， BARBOTIN A L， et al. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process［J］. Cell Metab， 2021， 33（3）： 513-530.e8.
41	CHEN B Q， XU P， WANG J， et al. The role of MiRNA in polycystic ovary syndrome （PCOS）［J］. Gene， 2019， 706： 91-96.
42	LONG W， ZHAO C， JI C B， et al. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers［J］. Cell Physiol Biochem， 2014， 33（5）： 1304-1315.
43	HOSSEINI E， SHAHHOSEINI M， AFSHARIAN P， et al. Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome［J］. Arch Med Sci， 2019， 15（4）： 887-895.
44	MUNAWAR LONE N， BABAR S， SULTAN S，et al. Association of the CYP17 and CYP19 gene polymorphisms in women with polycystic ovary syndrome from Punjab， Pakistan［J］. Gynecol Endocrinol， 2021， 37（5）： 456-461.
45	LI Y X， FANG L L， YAN Y， et al. Association between human SHBG gene polymorphisms and risk of PCOS： a meta-analysis［J］. Reprod Biomed Online， 2021， 42（1）： 227-236.
46	TIAN L F， ZOU Y， TAN J， et al. Androgen receptor gene mutations in 258 Han Chinese patients with polycystic ovary syndrome［J］. Exp Ther Med， 2021， 21（1）： 31.
47	CHEN J X， GUAN L B， LIU H W， et al. GALNT2 gene variant rs4846914 is associated with insulin and insulin resistance depending on BMI in PCOS patients： a case-control study［J］.Reprod Sci， 2021，28（4）：1122-1132.
48	TIAN Y， LI J Y， SU S Z， et al. PCOS-GWAS susceptibility variants in THADA， INSR， TOX3， and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS［J］. Front Endocrinol， 2020， 11： 274.
49	KARAKAYA C， ÇIL A P， BILGUVAR K， et al. Further delineation of familial polycystic ovary syndrome （PCOS） via whole-exome sequencing： PCOS-related rare FBN3 and FN₁ gene variants are identified［J］. J Obstet Gynaecol Res， 2022， 48（5）： 1202-1211.
50	SEYED ABUTORABI E， HOSSEIN RASHIDI B， IRANI S， et al. Investigation of the FSHR， CYP11， and INSR mutations and polymorphisms in Iranian infertile women with polycystic ovary syndrome （PCOS）［J］. Rep Biochem Mol Biol， 2021， 9（4）： 470-477.
51	ZOU J， WU D C， LIU Y， et al. Association of luteinizing hormone/choriogonadotropin receptor gene polymorphisms with polycystic ovary syndrome risk： a meta-analysis［J］.Gynecol Endocrinol，2019，35（1）： 81-85.
52	BHATNAGER R， JALTHURIA J， SEHRAWAT R， et al. Evaluating the association of TNF α promoter haplotype with its serum levels and the risk of PCOS： a case control study［J］. Cytokine， 2019， 114： 86-91.
53	HESAMPOUR F， NAMAVAR JAHROMI B， TAHMASEBI F，et al.Association between interleukin-32 and interleukin-17A single nucleotide polymorphisms and serum levels with polycystic ovary syndrome［J］. Iran J Allergy Asthma Immunol， 2019，18（1）： 91-99.
54	AL-AWADI A M， BABI， FINAN R R， et al. ADIPOQ gene polymorphisms and haplotypes linked to altered susceptibility to PCOS： a case-control study［J］. Reprod Biomed Online， 2022， 45（5）： 995-1005.

[1]	Hongmei TANG,Yuejiao LI,Xing WANG,Zhibin WANG,Xiefang YUAN,Xiaoyun WANG. Effect of Jiegeng Yuanshen Tang on airway inflammation and mucus secretion in allergic asthmatic mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 10-17.
[2]	Yang YU,Dan TIAN,Donghe NI,Duo ZHANG. Network pharmacologry and molecular docking analysis based on mechanism of monk fruit in treatment of diabetic nephropathy [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 161-167.
[3]	Xianguo XIE,Yabo MA,Yaxiu XU,Yan ZHANG,Changzheng DU,Jinrui XU,Yi YANG. Effect of CaMKⅡ on Caspase-3 expression of granulosa cells in mice with polycystic ovary syndrome model [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 968-974.
[4]	Zhouxin REN,Haibin YU,Xiaofeng MEI,Haoran DONG,Junling SHEN,Jiansheng LI. Improvement effect of Bufei Yishen prescription Ⅲ on experimental pulmonary hepertension of rats [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 280-288.
[5]	Dehong ZHANG,Mingzhu ZHENG,Jiaqiu LI,Zhong LU. Bioinformatics analysis based on expressions of MSR1 mRNA and protein in pan-cancer tissue and its significance [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 425-439.
[6]	Yaping YE,Yanfeng FAN,Lu DING,Longmei WANG,Ping LI. Effects of different serum levels of anti-mullerian hormone on pregnancy outcome of patients with polycystic ovary syndrome [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 501-507.
[7]	Junjie HOU,Xuguang MI,Xiaonan LI,Xiaonan LI,Ying YANG,Xiaodan LU,Yanqiu FANG,Ningyi JIN. Establishment and evaluation of prognostic model of lung adenocarcinoma based on lactate metabolism gene [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1546-1554.
[8]	Xuefeng ZHUANG,Guangfu LYU,He LIN,Xiaowei HUANG,Jia ZHOU,Yumo LI,Jiarui ZHAO,Zhe LIN,Yuchen WANG. Therapeutic effect and its mechanism of Astragali Radix on rhubarb-induced diarrhea in rats [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1156-1166.
[9]	Xin SHEN,Yang LIU,Hongyu CHEN,Jie ZHANG,Qingli CHENG,Guang YANG. Regulatory effect of high glucose on polarization of RAW264.7 macrophages via miR-125b in mice [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 847-857.
[10]	Shuyuan YU,Ping WANG,Xinrui WANG,Lanzi GONGGA,Li YANG. Effects of high altitude hypoxia on auditory conduction and peripheral auditory nerve myelin regeneration in plateau migrated rats [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 875-882.
[11]	Yihan WANG,Yidan WANG,Hetong HUI,Xinyuan FAN,Tianqi WANG,Wei XIA,Limei LIU. Detection of promoter methylation levels of Wnt5A and LINE-1 in serum during extramedullary infiltration in acute lymphoblastic leukemia transplanted tumor model mice and its significance [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 284-290.
[12]	Na HAN,Fanping LIU,Yanqing TIAN,Zhiqing ZHENG,Weiming LANG,Qian WANG,Yatao LIU,Jianguang ZHU. Regulatory effect of miRNA-27a on immune function in experimental pulmonary tuberculosis rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(1): 104-110.
[13]	Yanmin SUN,Junpan HU,Bingyu WANG,Jinying FU. Therapeutic effect of alpinetin in letrozole-induced polycystic ovary syndrome model rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(1): 129-135.
[14]	Song SU,Hongbo WANG,Yucong MA,Xin FANG,Junrong LIU,Hongmei QIAO. Kawasaki disease with inflammatory changes in parapharyngeal space:A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2022, 48(1): 228-233.
[15]	Mimi REN,Menghan GAO,Jing WANG,Jiamei LAI,Jinyu YU,Hang YUAN. Protective effect of 12/15-lipoxygenase gene knockout on kidney tissue of obesity-related glomerulopathy model mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1337-1346.

Research progress in etiology and pathogenesis of polycystic ovary syndrome

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 54

Related Articles 15

Metrics

Comments

Recommended 0